AstraZeneca on Friday became the second big drugmaker after Pfizer to cut a pricing deal with the White House, announcing an agreement alongside President Donald Trump at a late afternoon press conference. AstraZeneca stock was up 1.6% in Friday after-hours trading. AstraZeneca, which is headquartered in the United Kingdom but earned 43% of its revenues in the U.S. in 2024, committed to offer all of its prescription medications to Medicaid at “most favored nation prices”, which means “the lowest price anywhere in the world,” said Trump.
Continue Reading
View Comments
AstraZeneca Cuts Discounted Drug Pricing Deal With the White House. The Stock Is Rising.
Published 1 month ago
Oct 10, 2025 at 10:23 PM
Neutral
Auto